STAMFORD, Conn.--(BUSINESS WIRE)--Avrio Health L.P. (“Avrio”), a subsidiary of Purdue Pharma L.P. (“Purdue”), has donated shipments of Betadine Solution and Surgical Scrub to Direct Relief, advancing the company’s previous commitment to donate $1.6 million worth of Betadine antiseptic products (active ingredient, povidone-iodine or “PVP-I”) for use by frontline healthcare workers.
Betadine Solution and Betadine Surgical Scrub are antiseptic products for healthcare professionals to use to reduce the number of microorganisms on the skin that can potentially cause infection. Betadine antiseptic products have been used by healthcare professionals for more than 50 years. This donation follows previous product donations to New York State and Connecticut.
“We have supported Direct Relief both recently and historically with a COVID-19 special donation grant and product donations tied to hurricane relief efforts. We are thankful for the organization’s leadership and ingenuity during current and past health and humanitarian crises,” said Craig Landau, MD, president and CEO, Purdue Pharma. “Avrio’s latest donations are part of our ongoing efforts to support healthcare workers on the front lines as they continue to serve people in need during this pandemic.”
Purdue will continue to work with various interested parties and organizations, including state health officials and public health experts, to determine where future shipments of Betadine antiseptic products are most needed.
About Avrio Health L.P.
Avrio Health L.P., a subsidiary of Purdue Pharma L.P., is a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions. We have a strong portfolio of well-respected and proven effective brands, including Betadine®, Colace®, Senokot®, and SlowMag™ Mg.
About Purdue Pharma L.P.
Purdue Pharma and its subsidiaries develop and provide prescription medicines and consumer products that meet the evolving needs of healthcare professionals, patients, consumers and caregivers. We were founded by physicians and are currently led by a physician. Beyond our efforts to provide quality medications, Purdue Pharma is committed to supporting national, regional and local collaborations to drive innovations in patient care while also continuing our efforts to address the opioid crisis.
Purdue’s subsidiaries include: Adlon Therapeutics L.P., focused on treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders; Avrio Health L.P., a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions; Imbrium Therapeutics L.P., established to further advance the emerging portfolio and develop the pipeline in the areas of CNS, non-opioid pain medicines, and select oncology through internal research, strategic collaborations and partnerships; and Greenfield Bioventures L.P., an investment vehicle focused on value-inflection in early stages of clinical development.
For more information, visit www.purduepharma.com.
About Direct Relief
A humanitarian organization committed to improving the health and lives of people affected by poverty or emergencies, Direct Relief delivers lifesaving medical resources throughout the world to communities in need—without regard to politics, religion, or ability to pay. For more information, please visit https://www.DirectRelief.org.